Skip Navigation



ToxSci Advance Access published online on August 13, 2007

Toxicological Sciences, doi:10.1093/toxsci/kfm214
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow All Versions of this Article:
101/2/186    most recent
kfm214v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Klaassen, C. D.
Right arrow Articles by Lu, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klaassen, C. D.
Right arrow Articles by Lu, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Xenobiotic Transporters: Ascribing Function from Gene Knockout and Mutation Studies

Curtis D. Klaassen1 and Hong Lu

Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA

1 To whom correspondence should be addressed at Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160-7417, USA. Phone: (913)588-7500; Fax: (913)588-7501; E-mail: cklaasse{at}kumc.edu.

Received June 18, 2007; revision received August 6, 2007; accepted August 8, 2007


   Abstract

Transporter-mediated absorption, secretion, and reabsorption of chemicals are increasingly recognized as important determinants in the biological activities of many xenobiotics. In recent years, the rapid progress in generating and characterizing mice with targeted deletion of transporters has greatly increased our knowledge of the functions of transporters in the pharmacokinetics/toxicokinetics of xenobiotics. In this introduction, we focus on functions of transporters learned from experiments on knockout mice as well as humans and rodents with natural mutations of these transporters. We limit our discussion to transporters that either directly transport xenobiotics, or are important in biliary excretion or cellular defenses, namely multidrug resistance, multidrug resistance-associated proteins, breast cancer resistance protein, organic anion transporting polypeptides, organic anion transporters, organic cation transporters, nucleoside transporters, peptide transporters, bile-acid transporters, cholesterol transporters, and phospholipid transporters, as well as metal transporters. Efflux transporters in intestine, liver, kidney, brain, testes, and placenta can efflux xenobiotics out of cells and serve as barriers against the entrance of xenobiotics into cells, whereas many xenobiotics enter the biological system via uptake transporters. The functional importance of a given transporter in each tissue depends on its substrate specificity, expression level, and the presence/absence of other transporter(s) with overlapping substrate preferences. Nevertheless, a transporter may affect a tissue independent of its local expression by altering systemic metabolism. Further studies on the gene regulation and function of transporters, as well as the interrelationship between transporters and Phase-I/II xenobiotic-metabolizing enzymes, will provide a complete framework for developing novel strategies to protect us from xenobiotic insults.

Key Words: transporter; function; xenobiotics; knockout; mice.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
R. Evers and X.-Y. Chu
Role of the Murine Organic Anion-Transporting Polypeptide 1b2 (Oatp1b2) in Drug Disposition and Hepatotoxicity
Mol. Pharmacol., August 1, 2008; 74(2): 309 - 311.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. D. Lehman-McKeeman
Beam Me Up Scotty: Incorporating Transporters in Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling
Toxicol. Sci., July 1, 2008; 104(1): 1 - 3.
[Full Text] [PDF]


Home page
Toxicol SciHome page
H. Lu, S. Choudhuri, K. Ogura, I. L. Csanaky, X. Lei, X. Cheng, P.-z. Song, and C. D. Klaassen
Characterization of Organic Anion Transporting Polypeptide 1b2-null Mice: Essential Role in Hepatic Uptake/Toxicity of Phalloidin and Microcystin-LR
Toxicol. Sci., May 1, 2008; 103(1): 35 - 45.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.